Novel Role of DRA/SLC26A3 Downregulation in Gut Dysbiosis, Inflammation and Infection
DRA/SLC26A3 下调在肠道菌群失调、炎症和感染中的新作用
基本信息
- 批准号:10909515
- 负责人:
- 金额:$ 53.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-20 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAntibiotic TherapyBacteriaBicarbonatesButyratesCRISPR/Cas technologyCellsChloridesCitrobacter rodentiumColitisColonDataDefectDiarrheaDiseaseDown-RegulationElectrolytesEpitheliumEventExhibitsFecesGenesGenetic Predisposition to DiseaseGerm-FreeGoblet CellsHumanImmuneImmunologyImpairmentInfectionInflammationInflammatory Bowel DiseasesInflammatory ResponseInterventionIntestinesKnock-outKnockout MiceLymphoid CellMetagenomicsMicroclimateModelingMucin-2 Staining MethodMucinsMucous body substanceMusPathogenicityPhenotypePredispositionProductionRegulationRoleSLC26A3 geneSecondary toSodium BicarbonateStructureSusceptibility GeneTestingThinnessTimeTransgenic MiceTretinoinVolatile Fatty AcidsWaterWild Type Mouseabsorptionage relateddesigndrinking waterdysbiosisefficacy evaluationfecal transplantationgenome wide association studygut dysbiosisgut inflammationgut microbiomeinsightinterleukin-22intestinal barrierloss of function mutationmetabolomicsmicrobialmicrobiomemicrobiome alterationnano-stringnew therapeutic targetnoveloverexpressionpathogenreceptorresponserestorationtranscriptome sequencingtributyrin
项目摘要
Down regulated in adenoma (DRA) or SLC26A3 is the key intestinal chloride transporter involved in electrolyte and water absorption in the gut. Loss of function mutations in DRA result in “Congenital Chloride Diarrhea” or CLD disease. Extensive studies from our group have now established that downregulation of DRA is one of the key events in infectious and IBD-associated diarrhea. Emerging evidence from our group and others and GWAS studies have now also established DRA gene to be an IBD susceptibility locus. DRA knockout (KO) mice exhibit a CLD phenotype, thinner mucus layer and increased susceptibility to colitis. We recently showed that DRA KO mice exhibit some of the key features of IBD, including dysbiosis and compromised barrier integrity. Our preliminary studies further showed that DRA KO mice are more susceptible to pathogen infection and exhibit immune cell dysregulation. However, the detailed mechanisms underlying dysbiosis and its role in defective mucus-epithelial barrier observed in
DRAKO mice and their increased susceptibility to gut inflammation and pathogen infection have not been fully investigated. Our exciting data further showed that the dysbiosis in DRA KO mice was associated with decreased short chain fatty acid (SCFA) producing taxa, fecal SCFA levels and enrichment in mucin-degrading bacteria. Cohousing studies of DRA KO with wildtype mice showed that part of the compromised barrier integrity was secondary to microbial dysbiosis. Further, in preliminary studies, DRA KO mice showed a marked reduction in Innate Lymphoid Cells-3 and IL-22, critical for combating pathogen infection. Preliminary data also showed that the expression of key mucins (MUC2 and 4) was significantly higher in goblet cells but appeared to be trapped in cells suggesting abnormal secretion. Based upon these findings, our overall hypothesis is that “Gut dysbiosis in response to the loss of DRA function contribute
to compromised mucus and epithelial barrier integrity leading to increased susceptibility to gut inflammation and pathogen infection and strategies to upregulate DRA expression may alleviate these effects”. The key component of this hypothesis for this R56 proposal will be tested by the following Specific Aims: Aim 1a: Examine the age-dependent dynamic changes in the microbiome and mucus and epithelial barrier defects in DRA KO mice; Aim 1b: Investigate if cohousing with WT mice modulates the epithelium-associated factors including TJs, mucin synthesis and secretion; Aim 1c: Examine the role of altered bacterial species and metabolites by in-depth metabolomic and metagenomic analysis in DRA KO mice; Aim 1d: Evaluate the role of altered microbiome in affecting mucus layer and epithelial integrity via fecal microbial transplant approaches from WT and DRA KO mice to GF mice. The proposed studies will provide mechanistic insights into the role of DRA induced dysbiosis in defective mucus and epithelial barrier integrity and susceptibility to inflammation and infection and may aid in unraveling novel therapeutic targets.
在腺瘤(DRA)或SLC26A3中调节的下调是参与肠道中电解质和吸水的关键肠氯化物转运蛋白。 DRA中功能突变的丧失导致“先天性氯化物腹泻”或CLD疾病。我们小组的广泛研究已经确定,DRA的下调是传染和IBD相关的腹泻的关键事件之一。我们小组以及其他GWAS研究的新兴证据现在也确立了DRA基因成为IBD易感性基因座。 DRA敲除(KO)小鼠暴露了CLD表型,粘液层较薄,对结肠炎的敏感性增加。我们最近表明,DRA KO小鼠暴露了IBD的一些关键特征,包括营养不良和障碍障碍完整性。我们的初步研究进一步表明,DRA KO小鼠更容易受到病原体感染的影响,并表现出免疫细胞失调。然而,观察到的详细机制及其在有缺陷的粘液上皮屏障中的作用
Drako小鼠及其对肠道注射和病原体感染的敏感性增加尚未得到充分研究。我们的令人兴奋的数据进一步表明,DRA KO小鼠的营养不良与产生分类群,SCFA水平和粘液降解细菌富集的短链脂肪酸(SCFA)降低有关。与野生型小鼠对DRA KO的同座研究表明,障碍的一部分屏障完整性继发于微生物营养不良。此外,在初步研究中,DRA KO小鼠显示先天淋巴样细胞-3和IL-22的显着降低,对于打击病原体感染至关重要。初步数据还表明,杯状细胞中关键粘蛋白(MUC2和4)的表达明显更高,但似乎被困在表明异常分泌的细胞中。基于这些发现,我们的总体假设是“肠道营养不良响应DRA功能的丧失有助于
为了损害粘液和上皮屏障的完整性,导致对肠道注射和病原体感染的易感性增加,以及升级DRA表达的策略可能会减轻这些影响。小鼠;目标1B:是否与WT小鼠同居,包括TJ,粘蛋白合成和分泌的上皮相关因素:检查细菌和代谢物改变的作用通过WT和DRA KO小鼠到GF小鼠的粪便微生物移植方法的完整性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pradeep K Dudeja其他文献
Pradeep K Dudeja的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pradeep K Dudeja', 18)}}的其他基金
BCCMA: Targeting Gut-Microbiome in Veterans Deployment Related Gastrointestinal and Liver Diseases; CMA1- The Role of GWI Gut Microbiome in Susceptibility to Diarrheal Diseases
BCCMA:针对退伍军人部署相关胃肠道和肝脏疾病中的肠道微生物组;
- 批准号:
10485710 - 财政年份:2022
- 资助金额:
$ 53.34万 - 项目类别:
Mechanisms of Regulation of Intestinal Cl Absorption in IBD Associated Diarrhea
IBD 相关腹泻肠道 Cl 吸收的调节机制
- 批准号:
10620145 - 财政年份:2013
- 资助金额:
$ 53.34万 - 项目类别:
Mechanisms of NaCl Absorption in the Human Colon
人体结肠吸收 NaCl 的机制
- 批准号:
8774198 - 财政年份:2013
- 资助金额:
$ 53.34万 - 项目类别:
Mechanisms of NaCl Absorption in the Human Colon
人体结肠吸收 NaCl 的机制
- 批准号:
8442524 - 财政年份:2013
- 资助金额:
$ 53.34万 - 项目类别:
Mechanisms of Regulation of Intestinal Cl Absorption in IBD Associated Diarrhea
IBD 相关腹泻肠道 Cl 吸收的调节机制
- 批准号:
10347178 - 财政年份:2013
- 资助金额:
$ 53.34万 - 项目类别:
Transporter Trafficking Mechanisms in Infectious Diarrhea
传染性腹泻中的转运蛋白贩运机制
- 批准号:
8332247 - 财政年份:2011
- 资助金额:
$ 53.34万 - 项目类别:
Chloride Transporter Downregulation in Infectious Diarrhea
感染性腹泻中氯转运蛋白下调
- 批准号:
9177347 - 财政年份:2011
- 资助金额:
$ 53.34万 - 项目类别:
Transporter Trafficking Mechanisms in Infectious Diarrhea
传染性腹泻中的转运蛋白贩运机制
- 批准号:
8716742 - 财政年份:2011
- 资助金额:
$ 53.34万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CO型碳质球粒陨石富钙铝包体的26Al-26Mg年龄以及Ca-Ti同位素异常对早期太阳系星云环境的制约
- 批准号:42373039
- 批准年份:2023
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
A Randomized Pilot and Feasibility Study of a cultuRE-Directed approach to Urinary traCT Infection symptoms in older womeN: a mixed methods evaluation - the REDUCTION trial
针对老年女性尿路感染症状的文化导向方法的随机试验和可行性研究:混合方法评估 - REDUCTION 试验
- 批准号:
10586250 - 财政年份:2023
- 资助金额:
$ 53.34万 - 项目类别:
Patient reported outcomes in patients with nontuberculous mycobacterial pulmonary disease
非结核分枝杆菌肺病患者报告的结果
- 批准号:
10720789 - 财政年份:2023
- 资助金额:
$ 53.34万 - 项目类别:
Leveraging Molecular Technologies to Improve Diagnosis and Management of Pediatric Acute Respiratory Illness in Resource-Constrained Settings
利用分子技术改善资源有限环境中儿科急性呼吸系统疾病的诊断和管理
- 批准号:
10739603 - 财政年份:2023
- 资助金额:
$ 53.34万 - 项目类别:
Multispecies aggregates from human dental plaque nucleate highly diverse spatially structured oral biofilms on saliva coated surfaces
来自人类牙菌斑的多物种聚集体在唾液涂层表面上形成高度多样化的空间结构口腔生物膜
- 批准号:
10679723 - 财政年份:2023
- 资助金额:
$ 53.34万 - 项目类别:
Microbiome Contributions to Age-Associated Cognitive Decline
微生物组对年龄相关认知能力下降的影响
- 批准号:
10605551 - 财政年份:2023
- 资助金额:
$ 53.34万 - 项目类别: